Medication With Behavioral Telehealth Boosts Outcomes Beyond Weight Loss
An abstract presented at the ADA 85th Scientific Sessions showed that obesity telemedicine plus GLP-1 therapy yielded improvements in multiple outcomes.
An abstract presented at the ADA 85th Scientific Sessions showed that obesity telemedicine plus GLP-1 therapy yielded improvements in multiple outcomes.
Obesity drugs were not utilized often in young adults and adolescents despite high complication rates, prompting researchers to call for chronic, holistic care.
A study found plant‑based calorie restriction achieved similar weight loss as standard diets, with added benefits for uric acid and other markers.
Losing at least 5% of body weight reduces liver and visceral fat but decreases muscle mass, underscoring the need for muscle-preserving weight loss strategies.
The PATHWEIGH trial aims to embed structured obesity care into primary care, addressing barriers and boosting clinician confidence and patient outcomes.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.